National Comprehensive Cancer Network

About NCCN

Lunch Symposium Just Announced! The NCCN Value Initiative: Using Evidence Blocks™ in Clinical Decisions

On Saturday, October 17, 2015, join NCCN during the NCCN 10th Annual Congress: Hematologic Malignancies™ for a lunch symposium featuring the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Chronic Myelogenous Leukemia (CML) with NCCN Evidence Blocks™.

This lunch symposium will include panelists, Robert W. Carlson, MD, Chief Executive Officer, NCCN; and Jerald P. Radich, MD, Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Vice-Chair, NCCN Guidelines® panel for CML.

This session is open to congress attendees; advanced registration is not required. CME/CNE/CPE available. 

On October 16 – 17, 2015, the NCCN 10th Annual Congress will be held at the San Francisco Marriott Marquis in San Francisco, California.

The NCCN Annual Congress, which has been held in New York City in previous years, will be co-chaired by Ranjana H. Advani, MD, Stanford Cancer Institute, and Andrew D. Zelenetz, MD, Memorial Sloan Kettering Cancer Center.

Treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of breakthrough advances. In addition, targeted therapies and oral treatments bring the latest benefits to patients. This congress focuses on the new approaches that have been incorporated into patient management, including the use of drugs, biologics, and diagnostics.

New for 2015! Interactive Patient Case Studies & Panel Discussions where panelists will review and discuss interesting and challenging cases with the audience.

To view the full congress agenda or to register, visit NCCN.org/HEM.